冠心病患者内皮祖细胞与动脉弹性相关性及缬沙坦干预研究(3)
[8]Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood_derived endothe lial precursor cells augment postnatal neovascularization[J]. J Clin Invest,2 000,105(11):1527-1536.
[9]Rosenzweig A. Endothelial progenitor cells[J]. N Engl J Med,2003,348(7) :581-582.
[10]Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenit or cells: the missing link in atherosclerosis[J]? J Mol Med,2004,82(10):671 _677.
[11]Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endotheli al progenitor cells by statin therapy in patients with stable coronary artery di sease[J]. Circulation, 2001,103(24):2885-2890.
[12]Mcveigh GE, Burns DE, Filkellstein SM, et al. Reduced vascular compliance as a marker for hypertension[J]. Am J Hypertension,1991,4(3Pt1):245-251.
[13]Nigam A, Mitchell GF, Lambert J, et al. Relation between conduit vessel st iffness(assessed by tonometry) and endothelial function(assessed by flow_mediate d dilation) in patients with and without coronary heart disease[J]. Am J Card iol,2003,92(4):395-399.
[14]Shargorodsky M, Leibovitz E, Lubimov L，et al. Prolonged treatment with th e AT1 receptor blocker, valsartan, increases small and large artery compliance i n uncomplicated essential hypertension[J]. Am J Hypertens. 2002，15(12):10 87-1091.
[15]Bahlmann FH, de Groot K, Mueller O, et al. Stimulation of endothelial prog enitor cells: a new putative therapeutic effect of angiotensin Ii receptor antag onists[J]. Hypertension, 2005,45(4):526-529., 百拇医药(陈旭娇 王志军 何 浪)
[9]Rosenzweig A. Endothelial progenitor cells[J]. N Engl J Med,2003,348(7) :581-582.
[10]Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenit or cells: the missing link in atherosclerosis[J]? J Mol Med,2004,82(10):671 _677.
[11]Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endotheli al progenitor cells by statin therapy in patients with stable coronary artery di sease[J]. Circulation, 2001,103(24):2885-2890.
[12]Mcveigh GE, Burns DE, Filkellstein SM, et al. Reduced vascular compliance as a marker for hypertension[J]. Am J Hypertension,1991,4(3Pt1):245-251.
[13]Nigam A, Mitchell GF, Lambert J, et al. Relation between conduit vessel st iffness(assessed by tonometry) and endothelial function(assessed by flow_mediate d dilation) in patients with and without coronary heart disease[J]. Am J Card iol,2003,92(4):395-399.
[14]Shargorodsky M, Leibovitz E, Lubimov L，et al. Prolonged treatment with th e AT1 receptor blocker, valsartan, increases small and large artery compliance i n uncomplicated essential hypertension[J]. Am J Hypertens. 2002，15(12):10 87-1091.
[15]Bahlmann FH, de Groot K, Mueller O, et al. Stimulation of endothelial prog enitor cells: a new putative therapeutic effect of angiotensin Ii receptor antag onists[J]. Hypertension, 2005,45(4):526-529., 百拇医药(陈旭娇 王志军 何 浪)